in a multicenter , randomized clinical trial , the efficacy of ciprofloxacin plus azlocillin was compared with that of a standard regimen of ceftazidime plus amikacin for the initial empiric treatment of fever in neutropenic cancer patients .
C0008809
ciprofloxacin
C0015967
fever